Non-vitamin K Antagonist Oral Anticoagulants (NOAC) as an Alternative Treatment Option in Tumor-Related Venous Thromboembolism

BACKGROUND: The risk of venous thromboembolism (VTE) is 4 to 7 times higher in cancer patients than in the normal population. Moreover, cancer patients who take anticoagulants suffer more frequently from hemorrhagic complications and VTE recurrences. Patients often find low-molecular-weight heparin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Dtsch Arztebl Int
Autori principali: Beyer-Westendorf, Jan, Klamroth, Robert, Kreher, Stephan, Langer, Florian, Matzdorff, Axel, Riess, Hanno
Natura: Artigo
Lingua:Inglês
Pubblicazione: Deutscher Arzte Verlag 2019
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6401514/
https://ncbi.nlm.nih.gov/pubmed/30832760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2019.0031
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi